TRANSBIG is a translational research network of 40 world-class institutions in 22 countries. Learn more
NeoBIG is a new biomarkers and drug development research programme centred around neo-adjuvant studies. Learn more
Large-scale cooperation is crucial to make significant advances in breast cancer research, reduce the wasteful duplication of effort, and optimally serve those affected by the disease.
The Breast International Group (BIG), a non-profit organisation for academic breast cancer research groups, facilitates breast cancer research internationally by stimulating cooperation between its members and other academic networks, and collaborating with, but working independently from, the pharmaceutical industry.
Register now for IMPAKT 2010 and make sure you do not miss the opportunity to meet breast cancer researchers, scientists and clinicians to exchange opinions on the latest in breast cancer translational research.
BIG is looking for a Senior Clinical Trials Manager who will be responsible for the set-up and execution of international clinical studies (Phase II / III) or related research projects with a variety of partners.
Learn more about this job offer
Promoting the mobility of young scientists and researchers to develop their skills and knowledge within the breast cancer field, in particular the latest ‘omic’ technologies, TRANSBIG offers exceptional educational opportunities through its annual traineeship programme.
Deadline to apply for TRANSBIG traineeships is 9 April 2010. To view the available positions and learn about the requirements and the application process click here.
The Breast European Adjuvant Studies Team (BrEAST) is seeking applications for two medical oncology fellowships in clinical breast cancer research.
TRANSBIG Patients' Workshop 2010TRANSBIG traineeship programmeMINDACT BIG Clinical Trials
Subscribe here
